Long‐term safety of adalimumab in adult patients with plaque psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17366
Abstract: Adalimumab is a powerful drug used to treat psoriasis, that has been specially designed to mimic normal human molecules, and for this reason it is classed as a ‘biological’ drug. It reduces inflammation by inhibiting… read more here.
Keywords: long term; safety; per 100; aes per ... See more keywords
Adverse Events in Hospitalized Pediatric Patients
Sign Up to like & getrecommendations! Published in 2018 at "Pediatrics"
DOI: 10.1542/peds.2017-3360
Abstract: Rates of safety events in hospitalized children did not improve from 2007 to 2012. BrightcoveDefaultPlayer10.1542/6138647565001PEDS-VA_2017-3360 Video Abstract BACKGROUND: Patient safety concerns over the past 2 decades have prompted widespread efforts to reduce adverse events (AEs).… read more here.
Keywords: 1000 patient; aes per; per 1000; adverse events ... See more keywords